首页> 美国卫生研究院文献>Biomaterials Research >Engineered biomaterials for development of nucleic acid vaccines
【2h】

Engineered biomaterials for development of nucleic acid vaccines

机译:用于核酸疫苗开发的工程生物材料

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Nucleic acid vaccines have attracted many attentions since they have presented some superiority over traditional vaccines. However, they could only induce moderate immunogenicity. The route and formulation of nucleic acid vaccines have strong effects on the immune response and efficiency. Numerous biomaterials are used as a tool to enhance the immunogenicity of antigens. They deliver the antigens into the cells through particle- and non-particle-mediated pathway. However, challenges remain due to lack of comprehensive understanding of the actions of these biomaterials as a carrier/adjuvant. Herein, this review focuses on the evolution of biomaterials used for nucleic acid vaccines, discusses the advantages and disadvantages for gene delivery and immunostimulation of variety of structures of the biomaterials, in order to provide new thought on rational design of carrier/adjuvant and better understanding of mechanism of action in both immunostimulatory and delivery methods.
机译:核酸疫苗比传统疫苗具有某些优势,因此备受关注。但是,它们只能诱导中等的免疫原性。核酸疫苗的途径和配方对免疫反应和效率有很大影响。许多生物材料被用作增强抗原的免疫原性的工具。它们通过颗粒和非颗粒介导的途径将抗原递送到细胞中。然而,由于对这些生物材料作为载体/佐剂的作用缺乏全面的了解,挑战依然存在。在此,本综述着眼于核酸疫苗所用生物材料的发展,讨论了生物材料各种结构的基因传递和免疫刺激的优缺点,以便为合理设计载体/佐剂提供新思路,并更好地理解免疫刺激和递送方法的作用机理

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号